entertainment -WSS

entertainment

author：comprehensive 2025-09-27 12:36:08 - browse：3589

Drug shortages are a growing problem in the U.S., and a shortage of livesaving cancer drugs in particular has reached crisis levels.

On the latest episode of the “First Opinion Podcast,” oncologist Kristen Rice explains that drug shortages have been happening for several years but have been progressively worsening in the past few months. Oncologists are facing critical shortages of common, generic cancer medications and have even begun to ration care for certain patients who are able to delay treatment, according to Rice.

“Patients are already under a lot of stress — they’re dealing with a cancer diagnosis, and they’re terrified. The last thing they want to hear is that something that’s critical to controlling their cancer might not be available, and we’re wondering where the next dose is going to come from,” Rice said.

The conversation is based off Rice’s recent First Opinion, “Cancer drug shortages should have patients rioting in the streets.“

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： BioAge raises $170M for combination therapy with Zepbound

WSS

Emergency medicine has repudiated 'excited delirium.' Now what?

Biden's order seeks to regulate AI risk without stifling innovation

Doctors' information doesn't help them choose wisely when sick

Industry veterans launch new biotech VC with $310M

Chimpanzees, like humans and whales, get menopause: Study

Paying for Covid pills will soon shift to insurers

hotspot

entertainment

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

As demand for Covid shots wanes, Moderna seeks its next success

Emergency medicine has repudiated 'excited delirium.' Now what?

Medical leaders decry Supreme Court decision on affirmative action

Cassava reveals details — and problems — with Alzheimer's study

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Biogen Alzheimer’s drug launch off to slow start

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Gilead might be held responsible for not developing a drug

focus

Why Sanofi got shellacked over its spinoff

Why did Pfizer dish out millions for a Super Bowl ad?

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Gilead might be held responsible for not developing a drug

Physician subsidies by hospitals soar in wake of No Surprises Act

Cassava reveals details — and problems — with Alzheimer's study

entertainment

knowledge

explore

knowledge